comparemela.com

Latest Breaking News On - சினோ பார்மா குழு ஆஃப் நிறுவனங்கள் - Page 1 : comparemela.com

Mestron clarifies it does not have MoH s approval to distribute Covid-19 vaccines in Malaysia

Mestron clarifies it does not have MoH s approval to distribute Covid-19 vaccines in Malaysia The Edge 31/1/2021 Syahirah Syed Jaafar © Provided by The Edge KUALA LUMPUR (Jan 31): Mestron Holdings Bhd has issued a clarification to say that it did not obtain approval or a clearance letter from the Ministry of Health (MoH) to purchase or distribute Covid-19 vaccines in Malaysia. Instead, it clarified that its intention is to explore and venture into the vaccine distribution business by partnering with China-based Zhongyu Yexing (Chengdu) Industrial Co Ltd. The steel pole maker said this in a statement today after the MoH denied granting approval or issuing letters of permission to private parties for this purpose.

Steel pole maker Mestron plans to venture into Covid-19 vaccine distribution

KUALA LUMPUR (Jan 29): Mestron Holdings Bhd is the latest company to propose venturing into the Covid-19 vaccine distribution business. The steel pole maker said it has inked a Heads of Agreement (HOA) with China-based Zhongyu Yexing (Chengdu) Industrial Co Ltd to distribute the Covid-19 vaccine in Malaysia. In a statement, Mestron said it expects to invest up to RM20 million for this business venture, which will be funded via internally-generated funds, bank loans and proceeds from a private placement. Zhongyu is part of the Sino Pharma Group of Companies, and is one of the authorised distributors for Sinopharm’s China National Biotech Group Covid-19 vaccine.

Supermax, Top Glove, Mestron, Iris Corp, Homeritz, Uchi Technologies, KTG and Jerasia

KUALA LUMPUR (Jan 29): Based on corporate announcements and news flow today, stocks that may be in focus next Tuesday (Feb 2) include: Supermax Corp Bhd, Top Glove Corp Bhd, Mestron Holdings Bhd, Iris Corp Bhd, Homeritz Corp Bhd, Uchi Technologies Bhd, KTG Bhd and Jerasia Capital Bhd. Supermax Corp Bhd reported a new record net profit of RM1.06 billion for the second quarter ended Dec 31, 2020, up 34% from RM789.52 million in the preceding quarter. Quarterly revenue surged to RM2 billion from RM1.35 billion in the first quarter. This implies a net profit of nearly 50%. The anticipated big leap in earnings was mainly fuelled by higher average selling prices (ASPs), as demand for gloves continued to soar worldwide against the backdrop of the Covid-19 pandemic.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.